FBLN2 and major depressive disorder: In the study of depression, some scholars have demonstrated that the up-regulated expression level of miR-192-5p inhibits the activation of TGF-β1 signaling pathway by binding to Fbln2, thereby improving cognitive impairment and strengthening neurological function in the mouse model of depression (Tang et al., 2019).